Posted on 11/30/2015 11:00:35 AM PST by SeekAndFind
ISIS Pharmaceuticals could have a new name soon.
According to a report on Monday by CNNMoney's Matt Egan, the company is considering the switch following the terrorist attacks in Paris on Friday.
The attacks left 129 people dead and 352 wounded. ISIS, or the Islamic State of Iraq and Syria, claimed responsibility for the attacks.
ISIS Pharmaceuticals, which has the ticker ISIS, is a $7.2 billion biotech company that develops drugs that treat several conditions including cancer and heart conditions.
ISIS Pharma's vice president for corporate communications and investor relations D. Wade Walke told CNNMoney that Friday's attacks weighed on the company "quite a bit", and the negative associations with the terrorist group were not getting better over time.
That's a different tone to what CEO Stanley Crooke told CNBC's Jim Cramer in an interview last year.
Crooke said, "it drives me crazy ... our investors should be sophisticated. And we've been ISIS for 25 years, and I don't feel like I want to capitulate to these terrorists by changing my name. They can change their name."
(Excerpt) Read more at businessinsider.in ...
ORIGIN OF THE COMPANY NAME:
http://investorplace.com/2015/11/isis-pharmaceuticals/
IIsis Pharmaceuticals gets its named from an Egyptian goddess of health. It also doesn’t use its name on any brands, which means marketing issues aren’t problem for it.
How about Si,Si to court Hispanic business?
Yup, my first thought for a similar problem. https://en.wikipedia.org/wiki/Ayds
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.